当前位置: 首页 > 详情页

MicroRNA-200a suppresses migration and invasion and enhances the radiosensitivity of NSCLC cells by inhibiting the HGF/c-Met signaling pathway

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Department of Oncology and Radiotherapy, The Second Affiliated Hospital of Soochow University [2]Department of Pathology, School of Biology and Basic Medical Sciences, Soochow University, Suzhou, Jiangsu 215123 [3]Cancer Institute, Department of Radiation Oncology, Fudan University Shanghai Cancer Center [4]Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China
出处:
ISSN:

关键词: lung cancer miRNA-200a hepatocyte growth factor c-met signal pathway radiosensitivity

摘要:
Hepatocyte growth factor (HGF), an activator of the c-Met signaling pathway, is involved in tumor invasiveness, metastasis and radiotherapy resistance. In the present study, a novel HGF regulatory pathway in lung cancer involving microRNAs (miRNAs/miR) is described. Immunohistochemical staining and western blot analyses demonstrated that HGF was upregulated and associated with miR-200a downregulation in non-small cell lung cancer (NSCLC) samples compared with normal lung tissues. The association between HGF and miR-200a was associated with the degree of tumor malignancy and cell migration and invasion. miR-200a negatively regulated HGF expression by targeting the 3-untranslated region of the HGF mRNA. miR-200a overexpression induced HGF downregulation, decreased NSCLC cell migration and invasion, promoted apoptosis, and decreased cell survival in A549 and H1299 cells in response to ionizing radiation. The present results revealed a previously uncharacterized role of miRNA-200a in regulating tumor malignancy and radiosensitivity by suppressing HGF expression, a key factor in the HGF/c-Met pathway.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 3 区 医学
小类 | 4 区 肿瘤学
最新[2025]版:
大类 | 3 区 医学
小类 | 4 区 肿瘤学
JCR分区:
出版当年[2017]版:
Q3 ONCOLOGY
最新[2023]版:
Q2 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2017版] 出版当年五年平均 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者机构: [1]Department of Oncology and Radiotherapy, The Second Affiliated Hospital of Soochow University [3]Cancer Institute, Department of Radiation Oncology, Fudan University Shanghai Cancer Center
通讯作者:
通讯机构: [*1]Cancer Institute, Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Xuhui, Shanghai 200032, P.R. China [*2]Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Xuhui, Shanghai 200032, P.R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16996 今日访问量:0 总访问量:905 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院